Offloading — the redistribution of mechanical pressure away from a wound — is widely regarded as one of the most decisive interventions in healing diabetic foot ulcers. Repetitive pressure and shear on an insensate foot are central to why neuropathic plantar ulcers form and why they persist. Yet among the many components of wound care, the choice of offloading device is frequently the factor that most strongly determines whether an ulcer heals in weeks or lingers for months. This article reviews what recent peer-reviewed evidence says about offloading and why device selection matters so much.
Why Pressure Relief Drives Healing
In diabetic peripheral neuropathy, protective sensation is lost, so a patient continues to walk on an ulcerated area without the pain that would normally force rest. Each step reloads the wound bed, disrupting the fragile tissue that healing depends on. Reducing that plantar pressure allows granulation and re-epithelialization to proceed. The 2023 International Working Group on the Diabetic Foot (IWGDF) offloading guideline frames mechanical offloading as “arguably the most important” of the multiple interventions required to heal diabetes-related foot ulcers, placing it alongside infection control, vascular assessment, and wound care rather than treating it as an afterthought.
The Evidence for Non-Removable Knee-High Devices
The strongest and most consistent evidence favors non-removable knee-high devices — chiefly the total contact cast (TCC), a well-molded, minimally padded cast that maintains contact with the entire plantar surface and lower leg, and the non-removable knee-high walker. A 2023 systematic review and meta-analysis of twelve controlled studies involving 591 patients found that TCCs produced significantly higher healing rates than removable alternatives (risk ratio 1.22) and shortened healing time. The same analysis noted a higher rate of device-related complications, such as skin irritation, underscoring the need for skilled application and regular monitoring.
These findings echo an earlier meta-analysis of nineteen studies and 1,605 patients, which reported improved wound healing with total contact casting compared with removable cast walkers, therapeutic shoes, and conventional care, and found no advantage of irremovable cast walkers over the TCC. A 2024 meta-analysis conducted for the Italian diabetic foot guidelines reached a convergent conclusion: any plantar offloading outperformed no device, and total contact casts or non-removable knee-high walkers achieved higher healing rates than other offloading approaches (odds ratio 2.64).
Why Non-Removable Devices Outperform
The advantage of non-removable devices is thought to lie largely in enforced adherence. A removable boot only works while it is worn, and studies of activity have shown that patients often remove such devices for much of their daily stepping. A cast that cannot be taken off guarantees continuous protection. This is why the IWGDF recommends a non-removable knee-high device as the first-choice intervention for a neuropathic plantar forefoot or midfoot ulcer, reserving removable knee-high or ankle-high devices for situations where a non-removable device is contraindicated or not tolerated.
A Stepped, Individualized Approach
Guidelines describe offloading as a clinical pathway rather than a single product. When a non-removable device is unsuitable — for example, in the presence of significant ischemia or infection, or when a patient cannot accept it — a removable knee-high or ankle-high device is the second choice, and appropriately fitting footwear combined with felted foam is a third option. Where non-surgical offloading repeatedly fails to heal a forefoot ulcer, surgical offloading procedures such as Achilles tendon lengthening or metatarsal head resection may be considered. Contraindications, ulcer location, vascular status, and patient acceptability all shape the final choice.
Offloading is also central beyond ulceration. In acute Charcot neuro-osteoarthropathy, complete offloading with a total contact cast or knee-high device is a cornerstone of management; a 2024 cohort study of early-stage Charcot reported remission in 93% of patients treated with rigorous offloading, with major amputation in only one of 43. Once an ulcer heals, attention shifts to preventing recurrence, where therapeutic footwear and insoles have been shown to reduce relapse compared with regular footwear.
Key Takeaways
Across a decade of trials, meta-analyses, and international guidelines, the message is consistent: effective pressure relief is fundamental to healing neuropathic diabetic foot ulcers, and the device chosen matters. Non-removable knee-high offloading — the total contact cast and the non-removable walker — offers the best-supported healing outcomes and is recommended as first-line therapy, tempered by careful attention to contraindications, complication monitoring, and individual patient circumstances. When it cannot be used, a stepped hierarchy of removable devices, footwear modifications, and surgical options provides evidence-based alternatives. Recognizing offloading as a primary therapy, rather than an accessory to wound dressing, remains one of the clearest lessons of contemporary diabetic foot care.
References
Bus SA, Armstrong DG, Crews RT, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3647.
Li B, Lin A, Huang J, et al. Total contact casts versus removable offloading interventions for the treatment of diabetic foot ulcers: a systematic review and meta-analysis. Frontiers in Endocrinology. 2023;14:1234761.
Elraiyah T, Prutsky G, Domecq JP, et al. A systematic review and meta-analysis of off-loading methods for diabetic foot ulcers. Journal of Vascular Surgery. 2016;63(2 Suppl):59S–68S.
Gauna C, Romeo F, Scatena A, et al. Offloading systems for the treatment of neuropathic foot ulcers in patients with diabetes mellitus: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome. Acta Diabetologica. 2024;61(6):693–703.
Bittante C, Cerasari V, Bellizzi E, et al. Early treatment of acute stage 0/1 diabetic Charcot foot can avoid major amputations at one year. Journal of Clinical Medicine. 2024;13(6):1633.
Comments
